Sanofi’s CEO Quits Diabetes as Cancer Breakthroughs Beckon

Bookmark
(Bloomberg) -- Sanofi’s new chief executive, just three months into the job, is taking a scalpel to traditional areas of research to rejuvenate the sluggish French drugmaker.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.